A number of studies have shown that CD24 is an unfavorable marker in the Aldehyde Dehydrogenase 1 (ALDH1)-positive CD44+/CD24− breast cancer-initiating cells in human [2, 14, 15]. Here, CD24 is linked to breast cancer.